New Zealand markets close in 2 hours 19 minutes

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
61.73+0.30 (+0.49%)
At close: 04:00PM EDT
61.73 0.00 (0.00%)
After hours: 05:29PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
35,547
18,779
-47,896
-42,603
-22,548
Depreciation & amortisation
59,777
59,791
59,653
47,252
44,638
Deferred income taxes
-9,409
-11,740
-15,253
-16,754
-13,205
Stock-based compensation
23,248
20,652
14,599
10,489
12,936
Change in working capital
16,409
24,860
-51,300
-84
-12,628
Accounts receivable
2,295
3,359
-36,912
-5,548
-23,664
Inventory
-10,183
-5,841
-23,626
3,224
-2,759
Accounts payable
15,973
7,552
5,038
10,166
-2,294
Other working capital
95,065
100,448
-47,658
-20,316
-53,055
Other non-cash items
5,234
6,617
9,170
3,012
5,629
Net cash provided by operating activities
115,804
118,959
-31,203
3,322
15,267
Cash flows from investing activities
Investments in property, plant and equipment
-20,739
-18,511
-16,455
-23,638
-68,322
Acquisitions, net
-
0
-33
-84,494
0
Net cash used for investing activities
-7,225
-18,511
-15,738
-105,483
-68,322
Cash flows from financing activities
Debt repayment
-3,000
-3,000
-3,000
-211,010
-15,534
Common stock issued
-
80,555
0
69,584
0
Common stock repurchased
-10,099
-4,987
-1,959
-890
-1,523
Dividends paid
-1,625
-1,625
-1,625
-190
0
Other financing activities
-
-12,500
-
-19,384
-
Net cash used provided by (used for) financing activities
52,261
67,439
-5,126
194,595
-1,439
Net change in cash
160,840
167,887
-52,067
92,434
-54,494
Cash at beginning of period
67,757
53,234
105,301
12,867
67,361
Cash at end of period
228,597
221,121
53,234
105,301
12,867
Free cash flow
Operating cash flow
115,804
118,959
-31,203
3,322
15,267
Capital expenditure
-20,739
-18,511
-16,455
-23,638
-68,322
Free cash flow
95,065
100,448
-47,658
-20,316
-53,055